DPIIT recognised startup Government of India
Startup India
Remedise Pharma LLP - business services in Pune, Maharashtra, India. Directors, charges & compliance details.
Contribution obligation
₹60,000
As per LLP agreement
LLP age
5 yrs
Est. 2021
Designated partners
3
As per MCA filings
Active GSTINs
1
GST registered
Last financials
Mar 2025
Balance sheet date
LLP status
Active
MCA master data
Registrar
Pune
ROC office
Incorporated
25 Nov 2021
Date of incorporation
About Remedise Pharma LLP
Data last updated:
Remedise Pharma LLP is a limited liability partnership (LLP) based in Pune, Maharashtra, India, recognised as a startup by DPIIT. It operates in the commission-based trading segment of the business services sector. It was incorporated on 25 November 2021 and has been in existence for over 5 years.
The LLP is registered with the Registrar of Companies (ROC), Pune, under LLPIN AAZ-6390. Its GSTIN is 27ABEFR1685F1Z2 (Maharashtra).
The LLP has a total obligation of contribution of ₹60,000. It is led by designated partners including Amitraj Shivraj Mhetre and Arundhati Abhishek Karmalkar.
Its latest statement of accounts is for the year ended 31 March 2025. The registered office is at Sec.25 Plot.11 Flat.2 Sdc Nigadi Nigdi, Pune, Maharashtra, India – 411044.
For more details, the LLP can be reached via its website remedisepharma.com.
Company details
LLPIN AAZ-6390
Incorporation Date 25 November 2021
Total Obligation of Contribution ₹60,000
ROC Pune
Listing Status Unlisted
Company Status Active
Date of Last AGM 31 March 2025
Date of Balance Sheet 31 March 2025
DPIIT Recognition Recognised Startup
Key People
Amitraj Shivraj Mhetre Designated Partner Arundhati Abhishek Karmalkar Designated Partner Rupesh Baburao Meher Designated Partner Recognitions & Rankings of Remedise Pharma
Contact details
Remedise Pharma LLP's registered office is in Pune, Maharashtra.
- Registered AddressSec.25 Plot.11 Flat.2 Sdc Nigadi Nigdi, Pune, Maharashtra, India – 411044
- IndustryBusiness Services, Commission Trade, Wholesale
Comprehensive company report
Remedise Pharma LLP - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Financials of Remedise Pharma LLP
FY 2025 filings availableFinancial Statement Summary
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Income and Expenditure | ||||
| Turnover | ||||
| Other Income | ||||
| Total Income | ||||
| Purchases and Direct Costs | ||||
| Personnel Expenses | ||||
| Administrative Expenses | ||||
| Interest | ||||
| Depreciation | ||||
| Total Expenses | ||||
| Profit Before Tax | ||||
| Tax | ||||
| Profit After Tax | ||||
| Profit Transferred to Partners | ||||
| Assets and Liabilities | ||||
| Partners' Contribution | ||||
| Reserves and Surplus | ||||
| Secured Loans | ||||
| Unsecured Loans | ||||
| Trade Payables | ||||
| Other Liabilities and Provisions | ||||
| Total Liabilities | ||||
| Fixed Assets | ||||
| Investments | ||||
| Loans and Advances | ||||
| Inventories | ||||
| Trade Receivables | ||||
| Cash and Bank Balance | ||||
| Total Assets | ||||
Financial Ratios
| Statement of Account and Solvency | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|---|
| Profitability | ||||
| Net Profit Margin | ||||
| Return on Partners' Funds | ||||
| Return on Assets | ||||
| Liquidity and Debt | ||||
| Current Ratio | ||||
| Debt to Partners' Funds | ||||
| Interest Coverage | ||||
| Efficiency and Growth | ||||
| Asset Turnover | ||||
| Receivable Days | ||||
| Turnover Growth | ||||
| Profit Growth | ||||
To see the full financial statements and ratios of Remedise Pharma LLP, buy the company report.
Designated partners of Remedise Pharma LLP
Remedise Pharma has 3 current designated partners and 1 former designated partner. Current designated partners are listed first, with their designation and appointment date.
Current Designated Partners
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Amitraj Shivraj Mhetre | Designated Partner | 25 Nov 2021 | 4 Years 11 Months | Current |
| Arundhati Abhishek Karmalkar Also directs: Parivartan Healthcare LLP, Abhang Food Services LLP | Designated Partner | 25 Nov 2021 | 4 Years 11 Months | Current |
| Rupesh Baburao Meher Also directs: Kings Biopharma LLP | Designated Partner | 25 Nov 2021 | 4 Years 11 Months | Current |
Legal cases
No court or tribunal cases involving Remedise Pharma LLP are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Remedise Pharma LLP; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Remedise Pharma has 1 GST registration: 1 active.
Total GSTINs
1
Active
1
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 27ABEFR1685F1Z2 | Maharashtra | Active | 22 Dec 2021 |
To see the full GST registrations and return filing status of Remedise Pharma LLP, buy the company report.
Recent activity
Remedise Pharma LLP has 3 designated partner changes on record since 2021: 3 appointments. The latest: Amitraj Shivraj Mhetre was appointed as Designated Partner on 25 Nov 2021.
AGM
Remedise Pharma Llp last Annual general meeting of members was held on 31 Mar 2025 as per latest MCA records.
Filing
Remedise Pharma Llp has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Pune.
Appointed
Amitraj Shivraj Mhetre was appointed as Designated Partner.
Appointed
Arundhati Abhishek Karmalkar was appointed as Designated Partner.
Appointed
Rupesh Baburao Meher was appointed as Designated Partner.
Incorporation
25 Nov 2021
Remedise Pharma Llp was registered on 25 Nov 2021 with Roc Pune & aged 4 years 11 months as per MCA records.
Frequently asked questions
Remedise Pharma is an active limited liability partnership based in Pune, Maharashtra, India. The LLP works in commission trade, within the business services industry. It was incorporated on 25 November 2021 (5+ years old) and is registered under LLPIN AAZ-6390.
Remedise Pharma has 3 current designated partners:
- Amitraj Shivraj Mhetre - Designated Partner
- Arundhati Abhishek Karmalkar - Designated Partner
- Rupesh Baburao Meher - Designated Partner
The latest financial statements of Remedise Pharma on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 31 March 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Remedise Pharma is 27ABEFR1685F1Z2, registered in Maharashtra.
The LLPIN (Limited Liability Partnership Identification Number) of Remedise Pharma is AAZ-6390. It is issued by the Ministry of Corporate Affairs and uniquely identifies the LLP in India.
Remedise Pharma was incorporated on 25 November 2021, making it 5+ years old. It is registered with the Registrar of Companies, Pune.
Amitraj Shivraj Mhetre was appointed as Designated Partner on 25 Nov 2021. Arundhati Abhishek Karmalkar was appointed as Designated Partner on 25 Nov 2021. Rupesh Baburao Meher was appointed as Designated Partner on 25 Nov 2021.
Yes, Remedise Pharma is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Remedise Pharma can be reached through the website remedisepharma.com. Its registered office is in Pune, Maharashtra, India.
The registered office of Remedise Pharma is at Sec.25 Plot.11 Flat.2 Sdc Nigadi Nigdi, Pune, Maharashtra, India – 411044.